Contrast media (medium) or contrast agent is basically a substance that increases the structure’s contrast or the body’s fluid in medical imaging. The contrast agents intake, absorb or change the external electro-magnetism or the ultrasound. This is different from the radio-pharmaceuticals that release radiations themselves. In the x-rays, these contrast agents improve the radio density in structure of the target tissue. In the Magnetic Resonance Imaging scans, the contrast agents reduce the relaxation period or in few cases increase the body’s nuclei in the tissues in the body for changing or modifying the contrast image. The contrast media or the contrast agents are more prominently used to enhance the visibility of gastrointestinal tract or the blood vessels.
Contrast Media / Contrast Agents Market is estimated to be over US$ 4.7 Billion in 2018. It is anticipated to grow at a 3.8% CAGR from 2019 to 2030.
The continual growth of the contrast media/contrast agent market can be attributed to attributed to increasing number of approvals for contrast agents by regulatory authority, rise in number of public and private diagnostic centers, and rapidly growing global cancer population. The increasing number of research and funding activities for research using contrast agents and their applications provides immense opportunities for companies in the market.
Major Key Players of the Contrast Media / Contrast Agents Market are:
are GE healthcare, Bayer, Bracco Diagnostics, Guerbet, Lantheus, J.B. Chemicals and Pharmaceuticals, Daiichi Sankyo, Taejoon Pharm, and Jodas among others.
No comments:
Post a Comment